Home / Inspections / 1000616

FDA Inspection 1000616 — Vitalant Magee Women's Hospital Site

Vitalant Magee Women's Hospital Site — FEI 3004866289

The FDA completed an inspection of Vitalant Magee Women's Hospital Site on January 30, 2017 in Pittsburgh, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 30, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)

Facility

Other inspections at this facility

  • 1277487 (NAI Wed Jul 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1203720 (NAI Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1096150 (NAI Mon Jun 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 911620 (NAI Wed Jan 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 816136 (NAI Wed Jan 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources